Boron, chromium, molybdenum, and selenium often occur in high concentrations in fly ash leachates. During the leaching of fly ash in alkaline environments, hydrocalumite (Ca4Al2(OH)12(OH)2 x 6H2O) and ettringite (Ca6Al2(OH)12(SO4)3 x 26H20) form as secondary precipitates. In this study, the removal of B, Cr, Mo, and Se oxyanions from high pH waters by incorporation into hydrocalumite and ettringite was examined. Experiments were performed by precipitating these minerals in solutions containing B, Cr, Mo, and Se oxyanions at conditions relevant to lime-leaching of fly ash as well as to fly ash containing concrete. The uptake of all four anions by hydrocalumite and ettringite was high. Anion uptake by hydrocalumite was larger than that by ettringite, and hydrocalumite was able to reduce anion concentrations to below drinking water standards. Ettringite showed an anion preference in the order of B(OH)4- > SeO4(2-) > CrO4(2-) > MoO4(2-). In contrast, borate was least preferred by hydrocalumite. Coordination, size, and electronegativity are likely the factors that result in the observed differences among the oxyanions.

Tumour metastasis is an important reason for cancer death, and cancer cell migration is an important step in the process of tumour metastasis. Studying cancer cell migration is of great significance. Here, we present a novel microfluidic co-culture system and establish mild, moderate and severe cancer models by using HMEpiC and MDA-MB–231 cells to study cancer cell migration and anti-cancer drug screening. Using this device, we achieved high cell viability (over 90%) and a stable analysis of the migration ability of cancer cells. We observed that the density of the cancer cells determined the probability of the occurrence of metastatic cells and that the induction of normal cells affected the metastatic velocity of each cancer cell. We verified that the increase in the migration ability of MDA-MB-231 cells co-cultured with HMEpiC cells was relative to the increased secretion of IL-6 and that this was verified by an IL-6 inhibitor assay. This co-culture also led to decreased CK-14 secretion and morphological changes in HMEpiC cells. Finally, significant inhibition of paclitaxel and tamoxifen on cancer migration was observed. Taken together, our microfluidic device could be a useful tool for the quantitation of the migratory capability and anti-metastatic drug screening.

Survivin mediates paclitaxel-resistance in prostate cancer cells. The inhibition of Survivin sensitizes prostate cancer cells to paclitaxel-induced apoptosis through a caspase-dependant mechanism in vitro and in vivo.